RxDoctor Payments Data

Sarah Sher

Plastic Surgery · Asheville, NCNPI 1699090845

Payments from drug & device makers

What this record shows

The money is spread across several categories — speaking fees (56.5%), consulting fees and food and beverage — rather than concentrated in one kind of arrangement. AbbVie accounts for 89.1% of it on its own, with 10 other manufacturers making up the rest. Reporting peaked in 2023 at $21,955 and has fallen 89.5% since, to $2,303 in 2025.

$37,608in general payments, 2019–2025

Across 126 payments — averaging $298.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$34K
  • Mentor Worldwide LLC$2K
  • Motiva USA, LLC$1K
  • Sientra, Inc.$307
  • Sanara Medtech Inc.$118
  • Integra Lifesciences Corporation$95
  • plus $189 from 5 others

What the payments were for

  • Consulting fees$8,90124%
  • Speaking & faculty fees$21,26657%
  • Travel & lodging$2,4627%
  • Food & beverage$4,89213%
  • Gifts$870%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$37,608 in reported general payments places this provider in the 85th percentile of 128 plastic surgery providers in North Carolina.

See all plastic surgery providers in North Carolina

Medicare billing

Part B allowed, 2024
$67,338
Medicare patients
96
Services billed
198

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin11$23

Paid to pharmacies, not to this prescriber.

Other plastic surgery in Asheville

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →